SCHEMBL570846

SCHEMBL570846

COc1ccc(-c2ccn(C(C)C)n2)cn1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
CYP11B1 P15538 1/20 0.42
CYP2A6 P11509 2/20 0.42
CYP19A1 P11511 2/20 0.42
DYRK1A Q13627 1/20 0.41
JAK2 O60674 1/20 0.41
KCNH2 Q12809 1/20 0.41
MTOR P42345 2/20 0.40
FYN P06241 2/20 0.40
PIK3CA P42336 1/20 0.40
SYK P43405 1/20 0.40
MAPT P10636 1/20 0.40
KLK3 P07288 1/20 0.39
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
TNF P01375 1/20 0.39
KDR P35968 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13874174 0.81 KEAP1 (0.49) MKNK1MKNK2CYP11B1CYP2A6CYP19A1
SCHEMBL12777942 0.78 NPC1 (0.47) CYP19A1DYRK1AMAPT
SCHEMBL570269 0.76 TNF (0.46) MKNK1MKNK2CYP11B1CYP2A6CYP19A1
SCHEMBL19937856 0.74 PIK3CA (0.50) MTORFYNPIK3CAKDR
SCHEMBL21165960 0.73 DYRK1A (0.38) DYRK1A
SCHEMBL3754419 0.72 CYP2A6 (0.68) MKNK1MKNK2CYP2A6CYP19A1FYN
SCHEMBL31174412 0.72 CYP2A6 (0.68) MKNK1MKNK2CYP2A6CYP19A1FYN
SCHEMBL2609419 0.72 DYRK1A (0.45) DYRK1AMAPT
SCHEMBL16911662 0.72 MAPT (0.46) DYRK1AFYNMAPT
SCHEMBL28815229 0.71 DYRK1A (0.49) CYP11B1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601192-A1 FUSED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2013-06-12 EP disclosed
WO-2012018909-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-09 WO disclosed